We are live on ! Find out more
FQ

First Quadrant Portfolio holdings

AUM $18M
1-Year Est. Return 24.2%
This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+24.2%
3 Year Est. Return
+90.61%
5 Year Est. Return
+144.35%
10 Year Est. Return
AUM
$4.49B
AUM Growth
+$87.2M
Cap. Flow
-$70.7M
Cap. Flow %
-1.57%
Top 10 Hldgs %
16.01%
Holding
859
New
109
Increased
142
Reduced
182
Closed
54

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$26.9M
2
ELV icon
Elevance Health
ELV
+$26.5M
3
GILD icon
Gilead Sciences
GILD
+$20M
4
ZBRA icon
Zebra Technologies
ZBRA
+$18.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$18M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.8M
2
PKG icon
Packaging Corp of America
PKG
+$25.4M
3
AMGN icon
Amgen
AMGN
+$21.4M
4
HSY icon
Hershey
HSY
+$20.5M
5
EIX icon
Edison International
EIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Financials 16.33%
2 Technology 14.8%
3 Healthcare 13.84%
4 Industrials 13.25%
5 Energy 11.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFKT
801
DELISTED
Farmers Capital Bank Corp
FFKT
$2K ﹤0.01%
+99
New +$2K
IM
802
DELISTED
Ingram Micro
IM
$2K ﹤0.01%
82
VR
803
DELISTED
Validus Hold Ltd
VR
$1K ﹤0.01%
25
-94
-79% -$3.5K
AORT icon
804
Artivion
AORT
$1.34B
-6,500
Closed -$65K
AVY icon
805
Avery Dennison
AVY
$12.8B
-253,338
Closed -$12.8M
BSET icon
806
Bassett Furniture
BSET
$169M
-2,500
Closed -$37K
CSL icon
807
Carlisle Companies
CSL
$13.5B
-49,500
Closed -$3.93M
DAKT icon
808
Daktronics
DAKT
$946M
-4,400
Closed -$63K
EBS icon
809
Emergent Biosolutions
EBS
$379M
-52,100
Closed -$1.32M
FSS icon
810
Federal Signal
FSS
$6.82B
-55,900
Closed -$833K
HBI
811
DELISTED
Hanesbrands
HBI
-432,000
Closed -$8.26M
HLF icon
812
Herbalife
HLF
$1.3B
-164,200
Closed -$4.7M
HON icon
813
Honeywell
HON
$76.4B
-24,929
Closed -$2.08M
HVT icon
814
Haverty Furniture Companies
HVT
$418M
-2,300
Closed -$68K
PPLI
815
People Inc
PPLI
$3.12B
-690,473
Closed -$8.81M
IVR icon
816
Invesco Mortgage Capital
IVR
$759M
-260
Closed -$43K
LCII icon
817
LCI Industries
LCII
$2.59B
-3,200
Closed -$173K
MAS icon
818
Masco
MAS
$14.6B
-280,403
Closed -$5.47M
MD icon
819
Pediatrix Medical
MD
$2.2B
-60,600
Closed -$3.76M
MTRX icon
820
Matrix Service
MTRX
$312M
-7,700
Closed -$260K
OMC icon
821
Omnicom Group
OMC
$23.5B
-30,800
Closed -$2.24M
PHM icon
822
Pultegroup
PHM
$25.2B
-404,550
Closed -$7.76M
PTEN icon
823
Patterson-UTI
PTEN
$3.54B
-103,900
Closed -$3.29M
RITM icon
824
Rithm Capital
RITM
$5.58B
-4,800
Closed -$62K
SANM icon
825
Sanmina
SANM
$8.78B
-8,100
Closed -$141K

Similar funds

First Quadrant's Q2 2014 Portfolio in Review

As of Q2 2014, First Quadrant held 859 positions worth $4.49B, up 2% from $4.41B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

First Quadrant's Q2 2014 filing shows 109 new, 142 increased, 182 reduced and 54 closed positions. Its largest new stake was Harley-Davidson: 252,500 shares worth $17.6M. The largest sale was Biogen, an estimated $27.8M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • First Quadrant's largest Q2 2014 buy was Harley-Davidson: 252,500 shares worth $17.6M.
  • First Quadrant added most to Merck in Q2 2014, an estimated $26.9M increase.
  • First Quadrant's biggest Q2 2014 reduction was Biogen, cutting an estimated $27.8M.
  • First Quadrant fully exited BALLY TECHNOLOGIES, INC. in Q2 2014, selling an estimated $14.7M.
  • First Quadrant's ten largest holdings make up 16% of its $4.49B portfolio in Q2 2014.
  • First Quadrant opened 109 new positions and closed 54 in Q2 2014.
  • First Quadrant's portfolio value rose 2% quarter-over-quarter to $4.49B.

Based on First Quadrant's 13F filing for Q2 2014, filed 31 Jul 2014.